bioRxiv ScienceSearch

bioRxiv · 10.1101/2021.05.03.442542

Tropism, susceptibility, infectivity, and cytokine releases of differentiated human tonsillar epithelial cells by different Influenza viruses

Abstract

Human tonsil epithelium cells (HTEC) are a heterogeneous group of actively differentiating cells comprising stratified squamous epithelial and reticulated crypt cells with abundant keratin expression. We hypothesized that the tonsils are a primary site for influenza infection and sustained viral replication. Primary HTEC were grown using an air-liquid culture and infected apically with different influenza viruses (IVs) to measure viral growth kinetics. These cultures were highly differentiated, with subpopulations of heterogenous surface stratified squamous cells rich with both cilia and microvilli; these cells contained more 2,6-linked sialic acids, those preferentially bound by human IVs, than 2,3-linked avian like sialic acids. The stratified squamous cells were interrupted by patches of reticular epithelial cells rich in 2,3-linked sialic acids. The HTEC were permissive for influenza A and B virus replication. Following infection, a subset of cells, mostly ciliated cells, underwent apoptosis while others remained intact despite being positive for IV nucleoprotein. H3N2 virus antigen colocalized with non-ciliated cells while H1N1 virus antigen was mostly associated with ciliated cells. Exposure of HTECs to IVs triggers an early proinflammatory response that fluctuates between viruses. The H3N2 IV induces an early response that persists, whereas pH1N1 induces a primarily late response in HTECs. Our results implicated HTEC as a site for IV replication. The HTEC differentiated system provides a valuable in vitro model for studying cellular tropism, infectivity, cytokine responses and the pathogenesis of IVs. IMPORTANCETo develop an effective intervention against influenza, it is important to identify host factors affecting transmission, pathogenesis, and immune response. Tonsils are lymphoepithelial organs characterized by infiltration of B and T lymphocytes into the squamous epithelium of tonsillar crypts, beneath which germinal centers play key roles in antigen processing and immune response. The heterogenicity of HTECs as well as the sialic acid distributions supports the replication of IVs and may play a role in IV adaptation. Furthermore, Tonsillectomy is a surgical procedure in which tonsils are fully removed from the human throat and may contribute to the diverse outcomes among infected individuals.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Okda, F. A., Sakr, A. A., Webster, R. G., Webby, R. J.. 2021-05-04. Tropism, susceptibility, infectivity, and cytokine releases of differentiated human tonsillar epithelial cells by different Influenza viruses. https://doi.org/10.1101/2021.05.03.442542

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

De novo design of CR2 binder as vaccine scaffold

Efficient B cell activation during vaccine-induced humoral immunity relies on both B cell receptor (BCR) antigen recognition and synergistic signaling from co-receptors. Complement receptor 2 (CR2), the primary BCR co-receptor on B cells, lowers the activation threshold and amplifies downstream kinase signaling by orders of magnitude when engaged by complement fragment C3d decorated antigens. Targeting CR2 therefore represents a rational vaccine enhancement strategy, yet native C3d suffers from low affinity, poor stability, and manufacturing challenges. Here, we report the de novo design of a highly stable, high-affinity CR2 binder using deep learning driving protein design methods. Biophysical characterization, high-resolution cryoEM structural determination, and functional assays in vitro and in vivo confirm that the designed binder matches computational design models and specifically engages CR2 to boost B cell activation. When fused to antigen as a vaccine scaffold, the trimeric CR2 binder elicits robust humoral immune responses comparable to nanoparticle vaccines, while retaining the simplicity of single-chain protein production. Our work establishes a modular CR2 targeting vaccine scaffold platform with broad translational potential for next-generation protein vaccines.

immunology

Chronic opioid-associated immune dysregulation among people living with HIV

Objectives: Persistent immune dysregulation contributes to chronic disease among people living with HIV (PWH), even after viral suppression with antiretroviral therapy (ART). Although chronic opioid exposure is associated with adverse clinical outcomes, its impact on immune homeostasis during ART remains incompletely understood. We investigated whether opioid use disorder (OUD) is associated with persistent systemic and cellular immune dysregulation despite ART-mediated reductions in HIV viral load (VL). Methods: Peripheral blood was collected longitudinally from PWH with OUD (PWH/OUD+) and detectable HIV VL during 6 months of optimized ART (months 0, 3, and 6). A reference cohort of PWH without OUD (PWH/OUD-) and suppressed HIV VL provided a single blood sample. Immune profiling included plasma inflammatory biomarkers, multiplex cytokine analyses, spectral flow cytometry, and assessment of monocyte cytokine responses following lipopolysaccharide (LPS) stimulation. Mixed-effects models adjusted for HIV VL and VL-stratified analyses were performed. Results: PWH/OUD+ exhibited persistent immune dysregulation despite reductions in HIV VL. Plasma sCD163, sCD14, fractalkine, and I-TAC remained elevated, whereas TGF-{beta}1 was reduced. OUD was associated with expansion of CD16 monocytes and altered expression of CCR2, CD38, and CD11b. CD4 and CD8 T cells, NK cells, and B cells also exhibited persistent alterations in markers of activation, metabolism, and trafficking. Monocytes from PWH/OUD+ displayed attenuated cytokine responses following LPS stimulation. Conclusions: OUD is associated with persistent systemic and cellular immune dysfunction in PWH despite ART-mediated viral suppression, supporting opioid exposure as an independent contributor to chronic immune dysregulation that may promote inflammation, immune dysfunction, and long-term HIV-associated comorbidities. Keywords: HIV, Opioid-use disorder, innate immunity, cytokine

immunology

The mitochondrial RNA extrusion-induced innate immunity is regulated by N6-methyladenosine machinery

Mitochondrial RNA (mtRNA) released into the cytosol functions as a damage associated molecular pattern that activates pattern-recognition receptor (PRR)-mediated inflammation, yet its release mechanisms and cytoplasmic fate remain poorly understood. Here we report that chemical Abt-373-treatment and Vesicular stomatitis virus (VSV) infection induce mtRNA extrusion through Bax/Bak and VDAC1 channels, accompanied by mtDNA release. Extruded mtRNA in A549 cells activates multiple cytosolic PRRs, including RIG-I, MDA5, TLR3/7/8, and PKR, each contributing differentially to the innate immune signaling. Analysis of GEO datasets and methylated RNA immunoprecipitation (MeRIP) assays further reveals that mtRNA carries methyladenosine (m6A) modification. m6A machinery proteins are involved in the cytoplasmic retention time of mtRNA and its interaction with RIG-I, thereby modulating mtRNA-induced innate immunity. Thus, our work establishes in vitro models of mtRNA extrusion, and highlights m6A-dependent modulation as a potential therapeutic target for mtRNA-driven inflammation.

immunology